The approval of vedolizumab for the management of inflammatory bowel diseases in brazil: the beginning of a new biological era
Arq. gastroenterol
; 53(1): 3-4, Jan.-Mar. 2016.
Article
in En
| LILACS
| ID: lil-777111
Responsible library:
BR1.1
Full text:
1
Index:
LILACS
Main subject:
Colitis, Ulcerative
/
Crohn Disease
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Arq. gastroenterol
Journal subject:
GASTROENTEROLOGIA
Year:
2016
Type:
Article